Zobrazeno 1 - 10
of 209
pro vyhledávání: '"E. J. Topol"'
Autor:
A. Maroo, E. J. Topol
Publikováno v:
Journal of Thrombosis and Haemostasis. 2:1867-1870
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c3c05953608b9590b772dd02e1c880
https://doi.org/10.1111/j.1538-7836.2004.00881.x
https://doi.org/10.1111/j.1538-7836.2004.00881.x
Autor:
E J Topol, J M Estess
Publikováno v:
Heart. 87:308-311
Although fibrinolytic treatment of elderly patients is generally accepted, questions have been raised recently about its safety and efficacy. Fibrinolytic treatment is the standard of care for eligible patients presenting early with acute ST segment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7298b5a0b1d857f148f7efb2f6dd4a0e
https://doi.org/10.1136/heart.87.4.308
https://doi.org/10.1136/heart.87.4.308
Publikováno v:
Clinical genetics. 87(3)
Individuals who undergo multiplex direct-to-consumer (DTC) genomic testing receive genetic risk results for multiple conditions. To date, research has not investigated the influence of individual differences in disease perceptions among consumers on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::404b1774e234792ecd5d932221d5386f
https://pubmed.ncbi.nlm.nih.gov/24798746
https://pubmed.ncbi.nlm.nih.gov/24798746
Autor:
W. S. WILKE, E. J. TOPOL
Publikováno v:
Cleveland Clinic Journal of Medicine. 64:9-12
The optimal thrombolytic therapy will be a cocktail of several thrombolytic, antithrombotic, and antiplatelet agents, each of which attacks different pathways of clot formation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3deb7a906f9da363f5b8a4e8de2815c0
https://doi.org/10.3949/ccjm.64.1.9
https://doi.org/10.3949/ccjm.64.1.9
Publikováno v:
Clinical genetics. 84(4)
To describe consumers' perceptions of genetic counseling services in the context of direct-to-consumer personal genomic testing is the purpose of this research. Utilizing data from the Scripps Genomic Health Initiative, we assessed direct-to-consumer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5674f8795dba564a6421f8dfa42f1084
https://pubmed.ncbi.nlm.nih.gov/23590221
https://pubmed.ncbi.nlm.nih.gov/23590221
Publikováno v:
Cleveland Clinic Journal of Medicine. 63:124-128
A discussion of the pros and cons of different tools to assess the quality of medical care.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::084e5cbf69923599a510051fb45fdb52
https://doi.org/10.3949/ccjm.63.2.124
https://doi.org/10.3949/ccjm.63.2.124
Publikováno v:
Cleveland Clinic Journal of Medicine. 62:15-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b74938f28bb68ae23c6ba4b8b31098a5
https://doi.org/10.3949/ccjm.62.1.15
https://doi.org/10.3949/ccjm.62.1.15
Autor:
P. Theroux, C D Naylor, E. J. Topol, P Dorian, Judith S. Hochman, P. W. Armstrong, Jonathan S. Steinberg, C. D. Morgan
Publikováno v:
Circulation. 90:746-752
BACKGROUND Thrombolytic therapy reduces mortality after acute myocardial infarction, even when treatment is initiated relatively late after onset of symptoms. The mechanism underlying this survival benefit is incompletely understood. METHODS AND RESU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87cb2de9deccd610987d51ef661f01ff
https://doi.org/10.1161/01.cir.90.2.746
https://doi.org/10.1161/01.cir.90.2.746
Publikováno v:
Cleveland Clinic Journal of Medicine. 61:124-126
In this first in a new series of informal dialogues on controversial and emerging topics in cardiac diagnosis and therapy, two internationally known investigators tally the relative merits of atherectomy and angioplasty for percutaneous therapy of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb16e1365283d9b68f574209616f1171
https://doi.org/10.3949/ccjm.61.2.124
https://doi.org/10.3949/ccjm.61.2.124
Autor:
K, Kottke-Marchant, M C, Bahit, C B, Granger, P, Zoldhelyi, D, Ardissino, L, Brooks, J H, Griffin, R F, Potthoff, F, Van de Werf, R M, Califf, E J, Topol
Publikováno v:
European heart journal. 23(15)
We compared the effects of hirudin and heparin on thrombin generation and activity among 350 patients with acute coronary syndromes enrolled in the GUSTO-IIb trial.We obtained blood at baseline; at 4, 8, and 24h into infusion; at drug termination; an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::240b50c0113aae43620a320870100288
https://pubmed.ncbi.nlm.nih.gov/12127916
https://pubmed.ncbi.nlm.nih.gov/12127916